Cargando…

Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer

NLRP3 inflammasome was introduced as a double-edged sword in tumorigenesis and influenced immunotherapy response by modulating host immunity. However, a systematic assessment of the NLRP3-inflammasome-related genes across human cancers is lacking, and the predictive role of NLRP3 inflammasome in can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Mingyi, Bi, Jia, Wei, Qian, Jiang, Longyang, Guan, Qiutong, Zhang, Ming, Song, Xinyue, Chen, Ting, Fan, Jingyi, Li, Xiaojuan, Wei, Minjie, Zhao, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294515/ https://www.ncbi.nlm.nih.gov/pubmed/33212483 http://dx.doi.org/10.1093/bib/bbaa345

Ejemplares similares

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer
por: Ju, Mingyi, et al.
Publicado: (2022)

m(6)A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma
por: Chen, Lianze, et al.
Publicado: (2021)

A five‐mRNA signature associated with post‐translational modifications can better predict recurrence and survival in cervical cancer
por: Ju, Mingyi, et al.
Publicado: (2020)

Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
por: Liu, Aibin, et al.
Publicado: (2022)

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
por: Wang, Lin, et al.
Publicado: (2021)

Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer
por: Karan, Dev, et al.
Publicado: (2017)

Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma
por: Jiang, Longyang, et al.
Publicado: (2019)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay
por: Zhao, Lin, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation
por: Qin, Yan, et al.
Publicado: (2022)

Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation
por: Wei, Yanzhao, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

Role of the NLRP3 inflammasome in cancer
por: Moossavi, Maryam, et al.
Publicado: (2018)

Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives
por: Song, Jia, et al.
Publicado: (2022)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
por: Lin, Ting-Yi, et al.
Publicado: (2021)

Exosomes Regulate NLRP3 Inflammasome in Diseases
por: Li, Zhangwang, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

A pan‐cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness
por: Mei, Song, et al.
Publicado: (2023)

NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease: Role of NLRP3 inflammasome in autoimmune liver disease
por: Guan, Yanling, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
por: Cui, Zhiwei, et al.
Publicado: (2023)

Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
por: Xue, Yi, et al.
Publicado: (2019)

GIMAP7 as a Potential Predictive Marker for Pan-Cancer Prognosis and Immunotherapy Efficacy
por: Qin, Yan, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
por: Zhuang, Lingling, et al.
Publicado: (2023)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer
por: Li, Xueping, et al.
Publicado: (2020)

Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
por: Wang, Yiyang, et al.
Publicado: (2023)

Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: Insights and future perspectives
por: Qiao, Chu, et al.
Publicado: (2022)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
por: de Torre-Minguela, Carlos, et al.
Publicado: (2017)

Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
por: Du, Ren-Hong, et al.
Publicado: (2016)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

Implication of the NLRP3 Inflammasome in Bovine Age-Related Sarcopenia
por: De Biase, Davide, et al.
Publicado: (2021)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
por: Tu, Zewei, et al.
Publicado: (2023)

A potential immunotherapy target for breast cancer: parenchymal and immune-stromal expression of the NLRP3 inflammasome pathway
por: Zhu, Qian-mei, et al.
Publicado: (2023)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gj4c2jk6tkgas9ko7l48dbt4r1